Speciality

Professor, UCL Cancer Institute, London, UK 

Personal Information

After qualifying in medicine and surgery in 1986 from Oxford and UCL, Professor Bridgewater specialised in medical oncology at the Middlesex, Mount Vernon and Royal Marsden Hospitals.  He undertook a PhD in gene therapy at the Institute of Cancer Research, and subsequently accepted a senior lecturer position in medical oncology at UCL in 1999 in parallel with a consultant position at University College London Hospitals. 

Professor Bridgewater has led the National Cancer Research Institute (NCRI) Study Group in upper gastrointestinal malignancy and has directed several landmark studies in gastrointestinal (GI) malignancy.  He leads the Genomics England UGI theme, incorporating genomics into standard of care and research agendas. He specialises in the personalised oncology of gastrointestinal malignancies. 

Professor Bridgewater has served on several research and funding committees including the Clinical Trials Advisory and Awards Committee, ASCO, INSERM, INCa, MRC, KWF and National Institute for Health and Care Excellence committees.